ZPR1
Basic information
Region (hg38): 11:116773799-116788039
Previous symbols: [ "ZNF259" ]
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies | AR | Audiologic/Otolaryngologic; Renal | Among other findings, the condition can involve hearing loss, and early recognition and treatment of hearing impairment may improve outcomes, including speech and language development; As the condition can include renal anomalies, with morbidity and mortality reported to involve uremia, awareness may allow early interventions related to these manifestations | Audiologic/Otolaryngologic; Craniofacial; Dental; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal | 29851065 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (56 variants)
- not_provided (3 variants)
- Growth_restriction,_hypoplastic_kidneys,_alopecia,_and_distinctive_facies (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZPR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003904.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 54 | 61 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 1 | 0 | 55 | 5 | 1 |
Highest pathogenic variant AF is 0.000006156734
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ZPR1 | protein_coding | protein_coding | ENST00000227322 | 14 | 10331 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 8.95e-9 | 0.912 | 125701 | 0 | 47 | 125748 | 0.000187 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.726 | 216 | 248 | 0.870 | 0.0000126 | 3004 |
| Missense in Polyphen | 73 | 89.037 | 0.81988 | 1088 | ||
| Synonymous | 0.763 | 83 | 92.3 | 0.899 | 0.00000463 | 863 |
| Loss of Function | 1.81 | 17 | 27.2 | 0.625 | 0.00000155 | 296 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000206 | 0.000206 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000598 | 0.000598 |
| Finnish | 0.0000464 | 0.0000462 |
| European (Non-Finnish) | 0.000203 | 0.000202 |
| Middle Eastern | 0.000598 | 0.000598 |
| South Asian | 0.000163 | 0.000163 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a signaling molecule that communicates proliferative growth signals from the cytoplasm to the nucleus. Plays a role for the localization and accumulation of the survival motor neuron protein SMN1 in sub-nuclear bodies, including gems and Cajal bodies. Induces neuron differentiation and stimulates axonal growth and formation of growth cone in spinal cord motor neurons. Plays a role in the splicing of cellular pre-mRNAs. May be involved in H(2)O(2)-induced neuronal cell death. {ECO:0000269|PubMed:11283611, ECO:0000269|PubMed:17068332, ECO:0000269|PubMed:22422766}.;
- Pathway
- EGFR1
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- rvis_EVS
- 0.24
- rvis_percentile_EVS
- 69.37
Haploinsufficiency Scores
- pHI
- 0.340
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.518
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- gene_indispensability_score
Mouse Genome Informatics
- Gene name
- Zpr1
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; cellular phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;inner cell mass cell proliferation;trophectodermal cell proliferation;mRNA processing;signal transduction;cell population proliferation;RNA splicing;positive regulation of gene expression;spinal cord development;Cajal body organization;regulation of myelination;positive regulation of RNA splicing;DNA endoreduplication;positive regulation of protein import into nucleus;positive regulation of growth;axon development;cellular response to epidermal growth factor stimulus;positive regulation of transcription involved in G1/S transition of mitotic cell cycle;apoptotic process involved in development;pre-mRNA catabolic process;negative regulation of motor neuron apoptotic process
- Cellular component
- nucleus;nucleoplasm;nucleolus;cytoplasm;Cajal body;axon;growth cone;SMN complex;neuronal cell body;perikaryon;perinuclear region of cytoplasm;Gemini of coiled bodies
- Molecular function
- protein binding;zinc ion binding;receptor tyrosine kinase binding;translation initiation factor binding